3rd generation glp 1 GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness The Glucagon Paradox In Next-Generation

This reduction in glycemic variability is associated with reduced advanced glycation end-product formation, one of the cellular mechanisms linked to accelerated aging

These medications belong to the GLP-1 receptor agonist class and require weekly self-administered injections just under the skin

Sin embargo, estudios han demostrado que puede estar asociada con la prdida de peso en personas con diabetes tipo 15

doi: 10.1038/s42255-023-00859-y, 60 HarastaA

The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status

Elucidating the detailed mechanisms of Gq signaling in insulin and GLP-1 secretions may contribute to the development of new treatment strategies for diabetes